Status:
COMPLETED
Risk Factors and a nOmogram of Venous thromboEmbolism in Patients After liveR Transplantation(ROVER Study)
Lead Sponsor:
Beijing Tsinghua Chang Gung Hospital
Conditions:
Venous Thromboembolism
Liver Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
Liver transplantation is currently an effective treatment for end-stage liver disease. The high incidence of thrombotic related complications in the early postoperative period after orthotopic liver t...
Detailed Description
In this study, the investigators recruited adult inpatients who underwent orthotopic liver transplantation at Tsinghua Chang Gung Memorial Hospital, Beijing, from August 2018 to December 2021. The hos...
Eligibility Criteria
Inclusion
- Age ≥18 years old
- With orthotopic whole-liver transplantation
- Liver was obtained from Brain-dead organ donors
Exclusion
- Living donor liver transplantation, split liver transplantation, partial donor liver transplantation
- Multivisceral or combined organ transplantation
- Patients with preoperative VTE
- Age \< 18 years
- Died or discontinued surgery during surgery
- Those who died within 48 h after surgery or were discharged from hospital on their own resulting treatment discontinuity
- Patients with incomplete clinical data
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
356 Patients enrolled
Trial Details
Trial ID
NCT05209048
Start Date
August 1 2018
End Date
December 31 2021
Last Update
January 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tsinghua Chang Gung Hosipital
Beijing, Beijing Municipality, China, 102218